세계의 심장병 및 신경계 IVD 시장 규모, 점유율, 동향 분석 보고서, 제품 유형별, 최종 용도별, 기술별, 지역별 전망 및 예측(2023-2030년)

The Global IVD In Cardiology And Neurology Market size is expected to reach $29.9 billion by 2030, rising at a market growth of 9.3% CAGR during the forecast period.

North America is often at the forefront of technological advancements in healthcare. Consequently, the North America segment captured $6,288.5 million revenue in the market in 2022. In North America, the high incidence of chronic diseases (e.g., neurological disorders and cardiovascular conditions) increases the demand for diagnostic solutions. IVD tests are crucial in early detection, monitoring, and personalized treatment strategies. Thus, the segment will grow rapidly in the upcoming years.

The primary objective of public health campaigns and educational initiatives is to enhance public consciousness regarding the dangers and manifestations of neurological disorders and cardiovascular diseases (CVDs). Increased access to health information empowers individuals to be more proactive about their health. Informed patients are more likely to request diagnostic tests and screenings based on their understanding of risk elements and the importance of early detection.

Additionally, as the global population ages, there is a higher prevalence of age-related health conditions, including cardiovascular diseases and neurological disorders. According to a report published by the American College of Cardiology in April 2021, cardiovascular disease is Asia's leading cause of mortality. From 1990 to 2019, the number of cardiovascular-related fatalities in Asia increased from 5.6 million to 10.8 million. Moreover, as per Eurostat, in 2020, there were 194,000 deaths in the EU resulting from mental and behavioral disorders, equivalent to 3.7 % of all deaths.

However, the regulatory pathway for IVD tests in cardiology and neurology often involves intricate and prolonged approval processes. The costs and resources required to meet regulatory standards may divert attention and funds away from research and development efforts, hindering the introduction of cutting-edge technologies to address evolving diagnostic needs. The stringent regulatory environment can result in limited market access for certain players, especially those lacking the financial means to navigate the complex approval processes.

Moreover, the onset of the pandemic led to disruptions in routine healthcare services, affecting the adoption of IVD tests in cardiology and neurology. The limitations imposed by lockdowns and social distancing measures accelerated the adoption of telemedicine and remote patient monitoring. In cardiology, there was a notable increase in the use of home-based IVD tests to ensure continued patient care while minimizing in-person visits. Therefore, the COVID-19 pandemic positively impacted the market.

By Product Type Analysis

Based on product type, the market is segmented into instruments, reagents & consumables, and software & services. In 2022, the reagents and consumables segment garnered the 42.34% revenue share in the market. As the demand for diagnostic testing in cardiology and neurology rises, the need for reagents and consumables used in these tests tends to grow proportionately.

By End Use Analysis

Based on end-use, the market is divided into hospitals, clinical laboratories, and others. In 2022, the clinical laboratories segment witnessed a 26.70% revenue share in the market. The growing incidence of neurological and cardiovascular disorders has prompted a surge in need for diagnostic examinations.

By Technology Analysis

On the basis of technology, the market is divided into immunoassays, molecular diagnostics, hematology, and others. In 2022, the immunoassays segment witnessed the 38.08% revenue share in the market. Cardiology uses immunoassays to measure cardiac biomarkers such as troponins, creatine kinase-MB (CK-MB), and brain natriuretic peptide (BNP).

By Regional Analysis

By region, the market is segmented into North America, Europe, Asia Pacific, and LAMEA. In 2022, the Europe segment acquired a 28.81% revenue share in the market. Cardiology IVD tests in Europe often focus on cardiac biomarkers, lipid profiles, and genetic testing for hereditary cardiovascular conditions.

List of Key Companies Profiled

• Thermo Fisher Scientific, Inc.
• F. Hoffmann-La Roche Ltd.
• Sysmex Corporation
• Siemens Healthineers AG (Siemens AG)
• Quest Diagnostics Incorporated
• Abbott Laboratories
• Bio-Rad Laboratories, Inc.
• Danaher Corporation (Beckman Coulter, Inc.)
• Becton, Dickinson and Company
• Natera, Inc.

Global IVD In Cardiology And Neurology Market Report Segmentation

By Product Type

• Reagents & Consumables
• Instruments
• Software & Services

By End Use

• Hospitals
• Clinical Laboratories
• Others

By Technology

• Immunoassays
• Molecular Diagnostics
• Hematology
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1.Market Scope & Methodology

• 1.1Market Definition
• 1.2Objectives
• 1.3Market Scope
• 1.4Segmentation
  • 1.4.1Global IVD In Cardiology And Neurology Market, by Product Type
  • 1.4.2Global IVD In Cardiology And Neurology Market, by End Use
  • 1.4.3Global IVD In Cardiology And Neurology Market, by Technology
  • 1.4.4Global IVD In Cardiology And Neurology Market, by Geography
• 1.5Methodology for the research

Chapter 2.Market at a Glance

• 2.1Key Highlights

Chapter 3.Market Overview

• 3.1Introduction
  • 3.1.1Overview
    • 3.1.1.1Market Composition and Scenario
• 3.2Key Factors Impacting the Market
  • 3.2.1Market Drivers
  • 3.2.2Market Restraints
  • 3.2.3Market Opportunities
  • 3.2.4Market Challenges
• 3.3Porter's Five Forces Analysis

Chapter 4.Global IVD In Cardiology And Neurology Market by Product Type

• 4.1Global Reagents & Consumables Market by Region
• 4.2Global Instruments Market by Region
• 4.3Global Software & Services Market by Region

Chapter 5.Global IVD In Cardiology And Neurology Market by End-use

• 5.1Global Hospitals Market by Region
• 5.2Global Clinical Laboratories Market by Region
• 5.3Global Others Market by Region

Chapter 6.Global IVD In Cardiology And Neurology Market by Technology

• 6.1Global Immunoassays Market by Region
• 6.2Global Molecular Diagnostics Market by Region
• 6.3Global Hematology Market by Region
• 6.4Global Others Market by Region

Chapter 7.Global IVD In Cardiology And Neurology Market by Region

• 7.1North America IVD In Cardiology And Neurology Market
  • 7.1.1North America IVD In Cardiology And Neurology Market by Product Type
    • 7.1.1.1North America Reagents & Consumables Market by Country
    • 7.1.1.2North America Instruments Market by Country
    • 7.1.1.3North America Software & Services Market by Country
  • 7.1.2North America IVD In Cardiology And Neurology Market by End-use
    • 7.1.2.1North America Hospitals Market by Country
    • 7.1.2.2North America Clinical Laboratories Market by Country
    • 7.1.2.3North America Others Market by Country
  • 7.1.3North America IVD In Cardiology And Neurology Market by Technology
    • 7.1.3.1North America Immunoassays Market by Country
    • 7.1.3.2North America Molecular Diagnostics Market by Country
    • 7.1.3.3North America Hematology Market by Country
    • 7.1.3.4North America Others Market by Country
  • 7.1.4North America IVD In Cardiology And Neurology Market by Country
    • 7.1.4.1US IVD In Cardiology And Neurology Market
      • 7.1.4.1.1US IVD In Cardiology And Neurology Market by Product Type
      • 7.1.4.1.2US IVD In Cardiology And Neurology Market by End-use
      • 7.1.4.1.3US IVD In Cardiology And Neurology Market by Technology
    • 7.1.4.2Canada IVD In Cardiology And Neurology Market
      • 7.1.4.2.1Canada IVD In Cardiology And Neurology Market by Product Type
      • 7.1.4.2.2Canada IVD In Cardiology And Neurology Market by End-use
      • 7.1.4.2.3Canada IVD In Cardiology And Neurology Market by Technology
    • 7.1.4.3Mexico IVD In Cardiology And Neurology Market
      • 7.1.4.3.1Mexico IVD In Cardiology And Neurology Market by Product Type
      • 7.1.4.3.2Mexico IVD In Cardiology And Neurology Market by End-use
      • 7.1.4.3.3Mexico IVD In Cardiology And Neurology Market by Technology
    • 7.1.4.4Rest of North America IVD In Cardiology And Neurology Market
      • 7.1.4.4.1Rest of North America IVD In Cardiology And Neurology Market by Product Type
      • 7.1.4.4.2Rest of North America IVD In Cardiology And Neurology Market by End-use
      • 7.1.4.4.3Rest of North America IVD In Cardiology And Neurology Market by Technology
• 7.2Europe IVD In Cardiology And Neurology Market
  • 7.2.1Europe IVD In Cardiology And Neurology Market by Product Type
    • 7.2.1.1Europe Reagents & Consumables Market by Country
    • 7.2.1.2Europe Instruments Market by Country
    • 7.2.1.3Europe Software & Services Market by Country
  • 7.2.2Europe IVD In Cardiology And Neurology Market by End-use
    • 7.2.2.1Europe Hospitals Market by Country
    • 7.2.2.2Europe Clinical Laboratories Market by Country
    • 7.2.2.3Europe Others Market by Country
  • 7.2.3Europe IVD In Cardiology And Neurology Market by Technology
    • 7.2.3.1Europe Immunoassays Market by Country
    • 7.2.3.2Europe Molecular Diagnostics Market by Country
    • 7.2.3.3Europe Hematology Market by Country
    • 7.2.3.4Europe Others Market by Country
  • 7.2.4Europe IVD In Cardiology And Neurology Market by Country
    • 7.2.4.1Germany IVD In Cardiology And Neurology Market
      • 7.2.4.1.1Germany IVD In Cardiology And Neurology Market by Product Type
      • 7.2.4.1.2Germany IVD In Cardiology And Neurology Market by End-use
      • 7.2.4.1.3Germany IVD In Cardiology And Neurology Market by Technology
    • 7.2.4.2UK IVD In Cardiology And Neurology Market
      • 7.2.4.2.1UK IVD In Cardiology And Neurology Market by Product Type
      • 7.2.4.2.2UK IVD In Cardiology And Neurology Market by End-use
      • 7.2.4.2.3UK IVD In Cardiology And Neurology Market by Technology
    • 7.2.4.3France IVD In Cardiology And Neurology Market
      • 7.2.4.3.1France IVD In Cardiology And Neurology Market by Product Type
      • 7.2.4.3.2France IVD In Cardiology And Neurology Market by End-use
      • 7.2.4.3.3France IVD In Cardiology And Neurology Market by Technology
    • 7.2.4.4Russia IVD In Cardiology And Neurology Market
      • 7.2.4.4.1Russia IVD In Cardiology And Neurology Market by Product Type
      • 7.2.4.4.2Russia IVD In Cardiology And Neurology Market by End-use
      • 7.2.4.4.3Russia IVD In Cardiology And Neurology Market by Technology
    • 7.2.4.5Spain IVD In Cardiology And Neurology Market
      • 7.2.4.5.1Spain IVD In Cardiology And Neurology Market by Product Type
      • 7.2.4.5.2Spain IVD In Cardiology And Neurology Market by End-use
      • 7.2.4.5.3Spain IVD In Cardiology And Neurology Market by Technology
    • 7.2.4.6Italy IVD In Cardiology And Neurology Market
      • 7.2.4.6.1Italy IVD In Cardiology And Neurology Market by Product Type
      • 7.2.4.6.2Italy IVD In Cardiology And Neurology Market by End-use
      • 7.2.4.6.3Italy IVD In Cardiology And Neurology Market by Technology
    • 7.2.4.7Rest of Europe IVD In Cardiology And Neurology Market
      • 7.2.4.7.1Rest of Europe IVD In Cardiology And Neurology Market by Product Type
      • 7.2.4.7.2Rest of Europe IVD In Cardiology And Neurology Market by End-use
      • 7.2.4.7.3Rest of Europe IVD In Cardiology And Neurology Market by Technology
• 7.3Asia Pacific IVD In Cardiology And Neurology Market
  • 7.3.1Asia Pacific IVD In Cardiology And Neurology Market by Product Type
    • 7.3.1.1Asia Pacific Reagents & Consumables Market by Country
    • 7.3.1.2Asia Pacific Instruments Market by Country
    • 7.3.1.3Asia Pacific Software & Services Market by Country
  • 7.3.2Asia Pacific IVD In Cardiology And Neurology Market by End-use
    • 7.3.2.1Asia Pacific Hospitals Market by Country
    • 7.3.2.2Asia Pacific Clinical Laboratories Market by Country
    • 7.3.2.3Asia Pacific Others Market by Country
  • 7.3.3Asia Pacific IVD In Cardiology And Neurology Market by Technology
    • 7.3.3.1Asia Pacific Immunoassays Market by Country
    • 7.3.3.2Asia Pacific Molecular Diagnostics Market by Country
    • 7.3.3.3Asia Pacific Hematology Market by Country
    • 7.3.3.4Asia Pacific Others Market by Country
  • 7.3.4Asia Pacific IVD In Cardiology And Neurology Market by Country
    • 7.3.4.1China IVD In Cardiology And Neurology Market
      • 7.3.4.1.1China IVD In Cardiology And Neurology Market by Product Type
      • 7.3.4.1.2China IVD In Cardiology And Neurology Market by End-use
      • 7.3.4.1.3China IVD In Cardiology And Neurology Market by Technology
    • 7.3.4.2Japan IVD In Cardiology And Neurology Market
      • 7.3.4.2.1Japan IVD In Cardiology And Neurology Market by Product Type
      • 7.3.4.2.2Japan IVD In Cardiology And Neurology Market by End-use
      • 7.3.4.2.3Japan IVD In Cardiology And Neurology Market by Technology
    • 7.3.4.3India IVD In Cardiology And Neurology Market
      • 7.3.4.3.1India IVD In Cardiology And Neurology Market by Product Type
      • 7.3.4.3.2India IVD In Cardiology And Neurology Market by End-use
      • 7.3.4.3.3India IVD In Cardiology And Neurology Market by Technology
    • 7.3.4.4South Korea IVD In Cardiology And Neurology Market
      • 7.3.4.4.1South Korea IVD In Cardiology And Neurology Market by Product Type
      • 7.3.4.4.2South Korea IVD In Cardiology And Neurology Market by End-use
      • 7.3.4.4.3South Korea IVD In Cardiology And Neurology Market by Technology
    • 7.3.4.5Singapore IVD In Cardiology And Neurology Market
      • 7.3.4.5.1Singapore IVD In Cardiology And Neurology Market by Product Type
      • 7.3.4.5.2Singapore IVD In Cardiology And Neurology Market by End-use
      • 7.3.4.5.3Singapore IVD In Cardiology And Neurology Market by Technology
    • 7.3.4.6Malaysia IVD In Cardiology And Neurology Market
      • 7.3.4.6.1Malaysia IVD In Cardiology And Neurology Market by Product Type
      • 7.3.4.6.2Malaysia IVD In Cardiology And Neurology Market by End-use
      • 7.3.4.6.3Malaysia IVD In Cardiology And Neurology Market by Technology
    • 7.3.4.7Rest of Asia Pacific IVD In Cardiology And Neurology Market
      • 7.3.4.7.1Rest of Asia Pacific IVD In Cardiology And Neurology Market by Product Type
      • 7.3.4.7.2Rest of Asia Pacific IVD In Cardiology And Neurology Market by End-use
      • 7.3.4.7.3Rest of Asia Pacific IVD In Cardiology And Neurology Market by Technology
• 7.4LAMEA IVD In Cardiology And Neurology Market
  • 7.4.1LAMEA IVD In Cardiology And Neurology Market by Product Type
    • 7.4.1.1LAMEA Reagents & Consumables Market by Country
    • 7.4.1.2LAMEA Instruments Market by Country
    • 7.4.1.3LAMEA Software & Services Market by Country
  • 7.4.2LAMEA IVD In Cardiology And Neurology Market by End-use
    • 7.4.2.1LAMEA Hospitals Market by Country
    • 7.4.2.2LAMEA Clinical Laboratories Market by Country
    • 7.4.2.3LAMEA Others Market by Country
  • 7.4.3LAMEA IVD In Cardiology And Neurology Market by Technology
    • 7.4.3.1LAMEA Immunoassays Market by Country
    • 7.4.3.2LAMEA Molecular Diagnostics Market by Country
    • 7.4.3.3LAMEA Hematology Market by Country
    • 7.4.3.4LAMEA Others Market by Country
  • 7.4.4LAMEA IVD In Cardiology And Neurology Market by Country
    • 7.4.4.1Brazil IVD In Cardiology And Neurology Market
      • 7.4.4.1.1Brazil IVD In Cardiology And Neurology Market by Product Type
      • 7.4.4.1.2Brazil IVD In Cardiology And Neurology Market by End-use
      • 7.4.4.1.3Brazil IVD In Cardiology And Neurology Market by Technology
    • 7.4.4.2Argentina IVD In Cardiology And Neurology Market
      • 7.4.4.2.1Argentina IVD In Cardiology And Neurology Market by Product Type
      • 7.4.4.2.2Argentina IVD In Cardiology And Neurology Market by End-use
      • 7.4.4.2.3Argentina IVD In Cardiology And Neurology Market by Technology
    • 7.4.4.3UAE IVD In Cardiology And Neurology Market
      • 7.4.4.3.1UAE IVD In Cardiology And Neurology Market by Product Type
      • 7.4.4.3.2UAE IVD In Cardiology And Neurology Market by End-use
      • 7.4.4.3.3UAE IVD In Cardiology And Neurology Market by Technology
    • 7.4.4.4Saudi Arabia IVD In Cardiology And Neurology Market
      • 7.4.4.4.1Saudi Arabia IVD In Cardiology And Neurology Market by Product Type
      • 7.4.4.4.2Saudi Arabia IVD In Cardiology And Neurology Market by End-use
      • 7.4.4.4.3Saudi Arabia IVD In Cardiology And Neurology Market by Technology
    • 7.4.4.5South Africa IVD In Cardiology And Neurology Market
      • 7.4.4.5.1South Africa IVD In Cardiology And Neurology Market by Product Type
      • 7.4.4.5.2South Africa IVD In Cardiology And Neurology Market by End-use
      • 7.4.4.5.3South Africa IVD In Cardiology And Neurology Market by Technology
    • 7.4.4.6Nigeria IVD In Cardiology And Neurology Market
      • 7.4.4.6.1Nigeria IVD In Cardiology And Neurology Market by Product Type
      • 7.4.4.6.2Nigeria IVD In Cardiology And Neurology Market by End-use
      • 7.4.4.6.3Nigeria IVD In Cardiology And Neurology Market by Technology
    • 7.4.4.7Rest of LAMEA IVD In Cardiology And Neurology Market
      • 7.4.4.7.1Rest of LAMEA IVD In Cardiology And Neurology Market by Product Type
      • 7.4.4.7.2Rest of LAMEA IVD In Cardiology And Neurology Market by End-use
      • 7.4.4.7.3Rest of LAMEA IVD In Cardiology And Neurology Market by Technology

Chapter 8.Company Profiles

• 8.1Thermo Fisher Scientific, Inc.
  • 8.1.1Company Overview
  • 8.1.2Financial Analysis
  • 8.1.3Segmental and Regional Analysis
  • 8.1.4Research & Development Expenses
  • 8.1.5Recent strategies and developments:
    • 8.1.5.1Partnerships, Collaborations, and Agreements:
  • 8.1.6SWOT Analysis
• 8.2F. Hoffmann-La Roche Ltd.
  • 8.2.1Company Overview
  • 8.2.2Financial Analysis
  • 8.2.3Segmental and Regional Analysis
  • 8.2.4Research & Development Expense
  • 8.2.5SWOT Analysis
• 8.3Sysmex Corporation
  • 8.3.1Company Overview
  • 8.3.2Financial Analysis
  • 8.3.3Regional Analysis
  • 8.3.4Research & Development Expense
  • 8.3.5SWOT Analysis
• 8.4Siemens Healthineers AG (Siemens AG)
  • 8.4.1Company Overview
  • 8.4.2Financial Analysis
  • 8.4.3Segmental and Regional Analysis
  • 8.4.4Research & Development Expense
  • 8.4.5Recent strategies and developments:
    • 8.4.5.1Partnerships, Collaborations, and Agreements:
  • 8.4.6SWOT Analysis
• 8.5Quest Diagnostics Incorporated
  • 8.5.1Company Overview
  • 8.5.2Financial Analysis
  • 8.5.3Segmental Analysis
  • 8.5.4Recent strategies and developments:
    • 8.5.4.1Acquisition and Mergers:
  • 8.5.5SWOT Analysis
• 8.6Abbott Laboratories
  • 8.6.1Company Overview
  • 8.6.2Financial Analysis
  • 8.6.3Segmental and Regional Analysis
  • 8.6.4Research & Development Expense
  • 8.6.5Recent strategies and developments:
    • 8.6.5.1Partnerships, Collaborations, and Agreements:
    • 8.6.5.2Acquisition and Mergers:
  • 8.6.6SWOT Analysis
• 8.7Bio-Rad laboratories, Inc.
  • 8.7.1Company Overview
  • 8.7.2Financial Analysis
  • 8.7.3Segmental and Regional Analysis
  • 8.7.4Research & Development Expenses
  • 8.7.5SWOT Analysis
• 8.8Danaher Corporation (Beckman Coulter)
  • 8.8.1Company Overview
  • 8.8.2Financial Analysis
  • 8.8.3Segmental and Regional Analysis
  • 8.8.4Research & Development Expense
  • 8.8.5SWOT Analysis
• 8.9Becton, Dickinson, and Company
  • 8.9.1Company Overview
  • 8.9.2Financial Analysis
  • 8.9.3Segmental and Regional Analysis
  • 8.9.4Research & Development Expense
  • 8.9.5SWOT Analysis
• 8.10.Natera Inc.
  • 8.10.1Company Overview
  • 8.10.2Financial Analysis
  • 8.10.3Regional Analysis
  • 8.10.4Research & Development Expenses
  • 8.10.5SWOT Analysis

Chapter 9.Winning Imperatives of IVD In Cardiology And Neurology Market